Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 …
ML Robb, S Rerks-Ngarm, S Nitayaphan… - The Lancet infectious …, 2012 - thelancet.com
Summary Background The Thai phase 3 HIV vaccine trial RV 144 showed modest efficacy of
a vaccine against HIV acquisition. Baseline variables of age, sex, marital status, and risk did …
a vaccine against HIV acquisition. Baseline variables of age, sex, marital status, and risk did …
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 …
ML Robb, S Rerks-Ngarm… - The Lancet …, 2012 - pubmed.ncbi.nlm.nih.gov
Background The Thai phase 3 HIV vaccine trial RV 144 showed modest efficacy of a vaccine
against HIV acquisition. Baseline variables of age, sex, marital status, and risk did not modify …
against HIV acquisition. Baseline variables of age, sex, marital status, and risk did not modify …
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 …
ML Robb, S Rerks-Ngarm, S Nitayaphan… - The Lancet Infectious …, 2012 - Elsevier
BACKGROUND: The Thai phase 3 HIV vaccine trial RV 144 showed modest efficacy of a
vaccine against HIV acquisition. Baseline variables of age, sex, marital status, and risk did …
vaccine against HIV acquisition. Baseline variables of age, sex, marital status, and risk did …
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 …
ML Robb, S Rerks-Ngarm, S Nitayaphan… - The Lancet Infectious …, 2012 - infona.pl
The Thai phase 3 HIV vaccine trial RV 144 showed modest efficacy of a vaccine against HIV
acquisition. Baseline variables of age, sex, marital status, and risk did not modify vaccine …
acquisition. Baseline variables of age, sex, marital status, and risk did not modify vaccine …
Risk behaviour and time as covariates for effi cacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 …
ML Robb, S Rerks-Ngarm, S Nitayaphan… - 2012 - digitalcommons.unl.edu
Background The Thai phase 3 HIV vaccine trial RV 144 showed modest effi cacy of a
vaccine against HIV acquisition. Baseline variables of age, sex, marital status, and risk did …
vaccine against HIV acquisition. Baseline variables of age, sex, marital status, and risk did …
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: A post-hoc analysis of the Thai phase 3 …
ML Robb, S Rerks-Ngarm… - The Lancet …, 2012 - mahidol.elsevierpure.com
Background: The Thai phase 3 HIV vaccine trial RV 144 showed modest efficacy of a
vaccine against HIV acquisition. Baseline variables of age, sex, marital status, and risk did …
vaccine against HIV acquisition. Baseline variables of age, sex, marital status, and risk did …
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 …
ML Robb, S Rerks-Ngarm, S Nitayaphan… - 2012 - cabidigitallibrary.org
Abstract Background: The Thai phase 3 HIV vaccine trial RV 144 showed modest efficacy of
a vaccine against HIV acquisition. Baseline variables of age, sex, marital status, and risk did …
a vaccine against HIV acquisition. Baseline variables of age, sex, marital status, and risk did …
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 …
ML Robb, S Rerks-Ngarm, S Nitayaphan… - Lancet Infect …, 2012 - thelancet.com
Summary Background The Thai phase 3 HIV vaccine trial RV 144 showed modest efficacy of
a vaccine against HIV acquisition. Baseline variables of age, sex, marital status, and risk did …
a vaccine against HIV acquisition. Baseline variables of age, sex, marital status, and risk did …
[PDF][PDF] Risk behaviour and time as covariates for effi cacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase …
ML Robb, S Rerks-Ngarm, S Nitayaphan… - core.ac.uk
Summary Background The Thai phase 3 HIV vaccine trial RV 144 showed modest efficacy of
a vaccine against HIV acquisition. Baseline variables of age, sex, marital status, and risk did …
a vaccine against HIV acquisition. Baseline variables of age, sex, marital status, and risk did …
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 …
ML Robb, S Rerks-Ngarm, S Nitayaphan… - The Lancet. Infectious …, 2012 - europepmc.org
Background The Thai phase 3 HIV vaccine trial RV 144 showed modest efficacy of a vaccine
against HIV acquisition. Baseline variables of age, sex, marital status, and risk did not modify …
against HIV acquisition. Baseline variables of age, sex, marital status, and risk did not modify …